🔗 Share this article

An underground economy for unapproved weight-loss medications is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these profiles directly for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Additionally, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before directing buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Voice Worries

However, doctors and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in individuals administering products of unknown origin.

Several professionals stated the demand for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Platform Response and Material Removal

According to the social media company, the service has taken down violative content and prohibited related hashtags and query recommendations. The organization said it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.

Digital Trading Activities

Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of weight loss, positive testimonials and detailed guides for mixing or administering at residence.

After minutes of joining one group, a seller shared WhatsApp details, where the majority of transactions occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.

Product Information and Pricing

Within these groups, messages show dark colored packages with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service said it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they cannot confirm. Even if the science behind retatrutide is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has already encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject users to possibly significant medical dangers”.